Anagenics Limited (AU:AN1) has released an update.
Anagenics Limited reports a 10.6% rise in total revenue for the year ended June 30, 2024, but faces a significant increase in operating losses, up 190.4% from the previous year, to total $7,744,206. Despite sales growth from acquisitions and operational improvements, the company has suffered substantial asset impairments and is still striving to reach sustainable profitability. The company’s financial statements reveal a material uncertainty regarding its ability to continue, although a major shareholder has expressed willingness to provide support.
For further insights into AU:AN1 stock, check out TipRanks’ Stock Analysis page.